We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
-4.03%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$29.4B
AUM Growth
-$873M
(-2.9%)
Cap. Flow
+$534M
Cap. Flow
% of AUM
1.81%
Top 10 Holdings %
Top 10 Hldgs %
8.87%
Holding
3,036
New
582
Increased
766
Reduced
960
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$244M |
| 2 |
Enphase Energy
ENPH
|
+$229M |
| 3 |
GSK
GSK
|
+$223M |
| 4 |
Accenture
ACN
|
+$209M |
| 5 |
Citigroup
C
|
+$209M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$294M |
| 2 |
Amazon
AMZN
|
+$272M |
| 3 |
PayPal
PYPL
|
+$271M |
| 4 |
Bank of America
BAC
|
+$225M |
| 5 |
AVGOP
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.48% |
| 2 | Healthcare | 13.67% |
| 3 | Financials | 9.64% |
| 4 | Industrials | 8.71% |
| 5 | Consumer Discretionary | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Southern First Bancshares
SFST
$600M
| $739K | ﹤0.01% |
17,727
+2,777
| +19% | +$123K |
|
1577
Enanta Pharmaceuticals
ENTA
$400M
| $736K | ﹤0.01% |
14,192
+601
| +4% | +$35.1K |
|
1578
Alaunos Therapeutics
TCRT
$4.86M
| $734K | ﹤0.01% |
2,846
-226
| -7% | -$65.6K |
|
|
KZR
1579
DELISTED
Kezar Life Sciences
KZR
| $731K | ﹤0.01% |
8,485
-1,775
| -17% | -$172K |
|
|
FARO
1580
DELISTED
Faro Technologies
FARO
| $729K | ﹤0.01% |
26,561
-3,974
| -13% | -$130K |
|
1581
Alerus Financial
ALRS
$828M
| $728K | ﹤0.01% |
32,949
+2,385
| +8% | +$56.3K |
|
1582
Gorman-Rupp
GRC
$2.21B
| $726K | ﹤0.01% |
30,533
-16,709
| -35% | -$453K |
|
|
JBTM
1583
JBT Marel
JBTM
$6.39B
| $726K | ﹤0.01% |
+8,447
| New | +$896K |
|
1584
Avista
AVA
$3.24B
| $721K | ﹤0.01% |
19,463
+14,600
| +300% | +$611K |
|
1585
Heartland Express
HTLD
$956M
| $721K | ﹤0.01% |
50,396
-46,513
| -48% | -$699K |
|
1586
AdvanSix
ASIX
$444M
| $720K | ﹤0.01% |
22,429
+15,429
| +220% | +$555K |
|
|
PRVB
1587
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $719K | ﹤0.01% |
159,722
+99,995
| +167% | +$456K |
|
|
AERI
1588
DELISTED
Aerie Pharmaceuticals
AERI
| $719K | ﹤0.01% |
47,529
+17,700
| +59% | +$206K |
|
1589
FVCBankcorp
FVCB
$333M
| $718K | ﹤0.01% |
46,810
-44,356
| -49% | -$679K |
|
|
PTVE
1590
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $718K | ﹤0.01% |
82,264
+13,304
| +19% | +$138K |
|
|
PINE
1591
Alpine Income Property Trust
PINE
$352M
| $717K | ﹤0.01% |
44,229
-26,248
| -37% | -$472K |
|
1592
Parsons
PSN
$5.08B
| $717K | ﹤0.01% |
18,301
+2,201
| +14% | +$91.2K |
|
1593
Royal Gold
RGLD
$19.5B
| $717K | ﹤0.01% |
7,644
-195,945
| -96% | -$19.4M |
|
1594
American Vanguard Corp
AVD
$68.9M
| $716K | ﹤0.01% |
38,267
-100,464
| -72% | -$2.09M |
|
1595
IAMGOLD
IAG
$10.5B
| $713K | ﹤0.01% |
+666,518
| New | +$889K |
|
1596
CRA International
CRAI
$1.06B
| $712K | ﹤0.01% |
8,027
+1,200
| +18% | +$110K |
|
|
PENG
1597
Penguin Solutions Inc
PENG
$2.99B
| $711K | ﹤0.01% |
+44,800
| New | +$816K |
|
1598
Glaukos
GKOS
$10.6B
| $710K | ﹤0.01% |
+13,333
| New | +$688K |
|
1599
CNX Resources
CNX
$5.2B
| $708K | ﹤0.01% |
45,563
-129,815
| -74% | -$2.2M |
|
1600
Graco
GGG
$13.5B
| $708K | ﹤0.01% |
11,810
-5,834
| -33% | -$374K |
|
Similar funds
VAM
Two Sigma Investments's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Investments held 3,036 positions worth $29.4B, down 2.9% from $30.3B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
Two Sigma Investments's Q3 2022 filing shows 582 new, 766 increased, 960 reduced and 600 closed positions. Its largest new stake was Alphabet (Google) Class A: 2,198,196 shares worth $210M. The largest sale was Netflix, an estimated $294M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Two Sigma Investments's largest Q3 2022 buy was Alphabet (Google) Class A: 2,198,196 shares worth $210M.
- Two Sigma Investments added most to GSK in Q3 2022, an estimated $223M increase.
- Two Sigma Investments's biggest Q3 2022 reduction was Netflix, cutting an estimated $294M.
- Two Sigma Investments fully exited Bank of America in Q3 2022, selling an estimated $225M.
- Two Sigma Investments's ten largest holdings make up 8.9% of its $29.4B portfolio in Q3 2022.
- Two Sigma Investments opened 582 new positions and closed 600 in Q3 2022.
- Two Sigma Investments's portfolio value fell 2.9% quarter-over-quarter to $29.4B.
Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.